Study Links Serious Bleeding Risks to Diltiazem Combination Therapy With Anticoagulants for Atrial Fibrillation
Xarelto and Eliquis have already been linked to increased bleeding risks, which the new study says could be made worse by some hypertension drugs commonly prescribed as an atrial fibrillation combination therapy